Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

The rapidly changing treatment landscape of early triple negative breast cancer

Novel data in the field of immune checkpoint blockade for eTNBC

Date

13 Sep 2024

Session

The rapidly changing treatment landscape of early triple negative breast cancer

Topics

Immunotherapy

Tumour Site

Breast Cancer

Presenters

Sara Tolaney

Authors

S.M. Tolaney

Author affiliations

  • Dana Farber Cancer Institute, 02215 - Boston/US

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

How to treat stage I TNBC?

Presenter: David Cescon

Session: The rapidly changing treatment landscape of early triple negative breast cancer

Resources:

Slides

Webcast

Q&A and discussion

Session: The rapidly changing treatment landscape of early triple negative breast cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.